Inotiv, Inc.
West Lafayette, IN
- UEI
- QYU7HDLDQK16
- CAGE
- 58516
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 112990 All Other Animal Production
- 325413 In-Vitro Diagnostic Substance Manufacturing
- 334516 Analytical Laboratory Instrument Manufacturing
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- 519210 Libraries and Archives
- 541380 Testing Laboratories and Services
- 541519 Other Computer Related Services
- 541690 Other Scientific and Technical Consulting Services
- Corporate family
-
-
- Envigo RMS LLC · Indianapolis, IN E7TPXFCLHSU6
- YQ2LS5GYGGW3
-
- SAM.gov registration date
- Physical address
- 2701 Kent Ave, West Lafayette, IN 47906, USA
- Website
- basinc.com
- Founded
- 1974
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $12,000 |
| FY2024 | $70,690 |
| FY2023 | $24,273 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Non-GLP 3-strain ames assay | Office of Research and Development (EPA) | $12,000 | |
| Lab services | CDC Pittsburgh | $22,830 | |
| Pathology evaluation of mice lungs | CDC Pittsburgh | $35,860 | |
| Non-GLP ames assay services | Office of Research and Development (EPA) | $12,000 | |
| Pathology study | CDC Pittsburgh | $17,550 |
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| The Leland Stanford Junior University | 75N93020C00054 | $80,172 | |
| ICF Incorporated, L.L.C. | 75N96025C00003 | $650,000 | |
| The Leland Stanford Junior University | 75N93020C00054 | $166,622 | |
| Battelle Memorial Institute | 75N96024C00005 | $124,800 | |
| The Leland Stanford Junior University | 75N93020C00054 | $19,760 |
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Emory University | U19AI171403 | $132,900 | |
| Emory University | U19AI171403 | $170,000 | |
| Emory University | U19AI171403 | $157,980 | |
| Emory University | U19AI171403 | $111,600 | |
| Emory University | U19AI171403 | $41,750 |
Similar vendors
About the company
Inotiv, Inc., a for-profit manufacturer of goods and contract research organization headquartered in West Lafayette, Indiana, delivers preclinical toxicology, bioanalytical screening, pathology evaluation, and specialized laboratory services to federal agencies as a prime contractor (79% of recent awards) and as a subcontractor on biomedical research programs. The company operates through two named subsidiaries, Inotiv Research Models, LLC and Envigo RMS LLC, and competes in full-and-open procurements without set-aside designations across federal health, defense, and environmental agencies.
Inotiv's capability portfolio centers on nonclinical safety assessment, drug screening, and preclinical development services grounded in laboratory and animal research platforms. Recent prime contract work includes non-GLP Ames assay services for the EPA's Office of Research and Development ($12,000 firm fixed-price purchase order awarded April 2025), pathology evaluation of mouse lungs for CDC Pittsburgh ($35,860 awarded June 2024), and general laboratory services for CDC Pittsburgh ($22,830 awarded August 2024). The company also holds a $7.8 million indefinite delivery contract with EPA's Office of Research and Development for mammalian oral exposure studies through its Integrated Laboratory Systems subsidiary. On the grant side, Inotiv received a $1.835 million project grant from the Defense Health Agency (CFDA 12.420) in June 2024 to develop an APOL1 mouse platform for research into focal segmental glomerulosclerosis and chronic kidney disease, running through June 2028.
Customer concentration reflects heavy skew toward health research and development agencies. The top five funding sources by award count account for 35% of recent awards: the National Institute of Allergy and Infectious Diseases (20 awards), the Department of the Army (15 awards), the National Institute on Drug Abuse (6 awards), Army Medical Command (6 awards), and the National Institute of Environmental Health Sciences (5 awards). By combined potential value, the concentration shifts slightly; Army Medical Command dominates at $553,000 across six awards, followed by CDC Pittsburgh ($83,000 across four awards), the Food and Drug Administration ($34,000), and the National Institute of Child Health and Human Development ($32,000). Across thirty-five distinct federal customer agencies, Inotiv's work skews toward NIH institutes, Army medical research, CDC, and EPA environmental health programs.
Inotiv's most prominent parent vehicles are three General Services Administration Federal Supply Schedules (GS00F06920, GS00F78810, and GS00F5991A), each supporting multiple task orders, plus two specialized research-focused IDIQs: Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders and Support for Chemical Screening, Review, and Evaluation of New, Existing, and Safer Choice Chemical Substances. Award activity has accelerated in recent years—one award in 2022, three in 2023, six in 2024, and fourteen in both 2025 and 2026—indicating sustained or growing federal customer engagement. Top NAICS categories are Analytical Laboratory Instrument Manufacturing (27 awards) and Research and Development in the Physical, Engineering, and Life Sciences (24 awards), with supporting work in biotechnology R&D and medical instrument manufacturing.
In its subcontractor role, Inotiv performs preclinical toxicology, broad-spectrum antiviral development, and nonclinical safety assessment work under prime contracts with Stanford University (multiple COVID-19 antiviral chemistry sub-awards), Battelle Memorial Institute (National Institute of Environmental Health Sciences toxicology support including Ames testing and comet assay analysis), ICF Incorporated (National Toxicology Program scientific information management), Kelly Services (nonclinical safety studies in animal models), and Government Scientific Source Inc. (viral gene therapy genotoxicity studies for Menkes disease). Inotiv also functions as a sub-recipient under Emory University on the Antiviral Countermeasures Development Center grant program, with multiple sub-grant awards from March 2025 through June 2026. Service Contract Inventory data shows minimal SCI-reportable activity: only two sub-contract records spanning FY2024–FY2025 with approximately 0.4 to 1.9 FTEs delivered, indicating that Inotiv's federal services work falls primarily below the $150,000 SCI reporting threshold or is structured as goods and purchase orders rather than billable service contracts.
Quick answers
Is Inotiv, Inc. registered in SAM.gov?
Yes. Inotiv, Inc.'s SAM.gov registration is active through June 4, 2027.
How much has Inotiv, Inc. received in federal contracts?
Federal contracts obligated $12,000 to Inotiv, Inc. in fiscal year 2025 and $106,963 in fiscal years 2023 through 2027.
How does Inotiv, Inc. rank among federal contractors?
Inotiv, Inc. ranked #1 in PSC 88, #2 in NAICS 112 and #12 in PSC AJ15 in FY2025.
What is Inotiv, Inc.'s most recent federal award?
Inotiv, Inc.'s most recent federal contract award is Non-GLP 3-strain ames assay (68HE0B25P0363), from Office of Research and Development (EPA), on April 7, 2025.
On GovTribe
See Inotiv, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors